AU680740B2
(en)
*
|
1994-02-22 |
1997-08-07 |
Merrell Pharmaceuticals Inc. |
Novel indole derivatives useful to treat estrogen-related neoplasms and disorders
|
CA2203912A1
(en)
*
|
1995-09-01 |
1997-03-13 |
Dennis Michael Zimmerman |
Indolyl neuropeptide y receptor antagonists
|
GB9523999D0
(en)
|
1995-11-23 |
1996-01-24 |
Lilly Co Eli |
Indolyl neuropeptide y receptor antagonists
|
TW397821B
(en)
*
|
1996-04-19 |
2000-07-11 |
American Home Produits Corp |
3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
|
PT802183E
(pt)
*
|
1996-04-19 |
2002-03-28 |
American Home Prod |
Agentes estrogenicos
|
US5780497A
(en)
*
|
1996-04-19 |
1998-07-14 |
American Home Products Corporation |
2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
|
US5880137A
(en)
*
|
1996-04-19 |
1999-03-09 |
American Home Products Corporation |
2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
|
US5985910A
(en)
*
|
1996-04-19 |
1999-11-16 |
American Home Products Corporation |
3- [4- (2- Phenyl-Indole-1-ylmethyl) Phenyl]- Acrylamides as estrogenic agents
|
US5998402A
(en)
*
|
1996-04-19 |
1999-12-07 |
American Home Products Corporation |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
|
FR2751966B1
(fr)
*
|
1996-08-01 |
1998-10-30 |
Union Pharma Scient Appl |
Nouveaux derives 1,2-diarylindoles, leurs procedes de preparation, et leurs utilisations en therapeutique
|
AR016827A1
(es)
*
|
1997-08-22 |
2001-08-01 |
Smithkline Beecham Corp |
PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
|
US6005102A
(en)
|
1997-10-15 |
1999-12-21 |
American Home Products Corporation |
Aryloxy-alkyl-dialkylamines
|
US6326392B1
(en)
|
1997-11-06 |
2001-12-04 |
American Home Products Corporation |
Anti-estrogen plus progestin containing oral contraceptives
|
CA2331631A1
(en)
*
|
1998-05-12 |
1999-11-18 |
American Home Products Corporation |
Benzocarbazoles and indenoindoles as estrogenic agents
|
US6069153A
(en)
*
|
1998-05-12 |
2000-05-30 |
American Home Products Corporation |
Indenoindoles and benzocarbazoles as estrogenic agents
|
JP2002515431A
(ja)
*
|
1998-05-15 |
2002-05-28 |
アメリカン・ホーム・プロダクツ・コーポレイション |
エストロゲンと組み合わせる2−フェニル−1−[4−(2−アミノエトキシ)ベンジルオキシ]インドール
|
US6479535B1
(en)
*
|
1998-05-15 |
2002-11-12 |
Wyeth |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
|
JP2002515484A
(ja)
*
|
1998-05-15 |
2002-05-28 |
アメリカン・ホーム・プロダクツ・コーポレイション |
2−フェニルインドール化合物およびエストロゲン製剤からなる組成物
|
WO2000050386A1
(en)
|
1999-02-26 |
2000-08-31 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
EP1159268A1
(en)
*
|
1999-03-04 |
2001-12-05 |
American Home Products Corporation |
N-SUBSTITUTED BENzOYL INDOLES AS ESTROGENIC AGENTS
|
US6380185B1
(en)
|
1999-03-04 |
2002-04-30 |
American Home Products Corporation |
N-substituted benzoyl indoles as estrogenic agents
|
RU2001129155A
(ru)
|
1999-03-26 |
2003-08-10 |
Еро-Сельтик С.А. (Lu) |
Соединения с арильными заместителями (варианты), фармацевтическая композиция и способ лечения расстройства, чувствительного к блокаде натриевых каналов у млекопитающего, способ лечения, профилактики различных заболеваний или уменьшения интенсивности гибели или потери нейронов (варианты), способ облегчения или предупреждения эпилептических припадков у животного (варианты), соединение - радиоактивный лиганд для участка связывания в натриевом канале
|
US6159959A
(en)
*
|
1999-05-06 |
2000-12-12 |
American Home Products Corporation |
Combined estrogen and antiestrogen therapy
|
CN1196708C
(zh)
*
|
1999-09-13 |
2005-04-13 |
惠氏公司 |
2-(4-羟基-苯基)-1-[4-(2-氨-1-基-乙氧基)-苄基]-1h-吲哚-5-酚的吡喃葡糖苷轭合物
|
US6380166B1
(en)
|
1999-09-13 |
2002-04-30 |
American Home Products Corporation |
Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
|
DE19962300A1
(de)
*
|
1999-12-23 |
2001-06-28 |
Asta Medica Ag |
Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
|
DE10117441A1
(de)
*
|
2001-04-03 |
2002-10-10 |
Schering Ag |
1-Indolylderivate, deren Verwendung zur Herstellung von Arzneimitteln, ein Verfahren zur Herstellung der 1-Indolylderivate sowie 1-Indolylderivate enthaltende pharmzeutische Präparate
|
AU2002317377A1
(en)
*
|
2001-07-20 |
2003-03-03 |
Cancer Research Technology Limited |
Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
|
PL374845A1
(en)
|
2002-07-22 |
2005-11-14 |
Eli Lilly And Company |
Selective estrogen receptor modulators containing a phenylsulfonyl group
|
GB0224557D0
(en)
*
|
2002-10-22 |
2002-11-27 |
Glaxo Group Ltd |
Novel compounds
|
WO2005056522A2
(en)
*
|
2003-12-04 |
2005-06-23 |
National Health Research Institutes |
Indole compounds
|
CA2558051C
(en)
*
|
2004-03-16 |
2013-03-12 |
Boehringer Ingelheim International Gmbh |
Palladium catalyzed indolization of 2-bromo or chloroanilines
|
DOP2006000016A
(es)
*
|
2005-01-26 |
2006-07-31 |
Aventis Pharma Inc |
2-fenil-indoles como antagonistas del receptor de la prostaglandina d2.
|
NZ585389A
(en)
|
2007-10-16 |
2011-10-28 |
Repros Therapeutics Inc |
Trans-clomiphene for metabolic syndrome
|
US7750027B2
(en)
*
|
2008-01-18 |
2010-07-06 |
Oxagen Limited |
Compounds having CRTH2 antagonist activity
|
MX2014009322A
(es)
|
2012-02-29 |
2014-11-10 |
Repros Therapeutics Inc |
Terapia de combinacion para el tratamiento de la deficiencia androgenica.
|
GB201407820D0
(en)
|
2014-05-02 |
2014-06-18 |
Atopix Therapeutics Ltd |
Polymorphic form
|
GB201407807D0
(en)
|
2014-05-02 |
2014-06-18 |
Atopix Therapeutics Ltd |
Polymorphic form
|
WO2017081171A1
(en)
|
2015-11-10 |
2017-05-18 |
Paracrine Therapeutics Ab |
Treatment of er-negative breast cancer with an pdgf-cc inhibitor and an anti estrogen
|